Zachariah Weilenman, MD
Pain Medicine · Gulf Breeze, FLNPI 1174028104
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,609 of the $5,501 with a category attached, or 65.6%. Boston Scientific accounts for 61.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $2,003 and has fallen 57.3% since, to $854 in 2025.
Across 61 payments — averaging $90.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$394
- SPR Therapeutics, Inc$331
- AbbVie$286
- Avanos Medical$270
- Merz Pharmaceuticals, LLC$260
- plus $552 from 7 others
What the payments were for
- Travel & lodging$1,81333%
- Food & beverage$3,60966%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 27 | $3,408 |
| Abbott | 7 | $394 |
| SPR Therapeutics, Inc | 3 | $331 |
| AbbVie(2 entities) | 7 | $286 |
| Avanos Medical | 2 | $270 |
| Merz Pharmaceuticals, LLC | 4 | $260 |
| Nalu Medical, Inc. | 1 | $150 |
| Medtronic | 3 | $133 |
| Averitas Pharma Inc. | 2 | $118 |
| Nevro Corp. | 1 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Bioventus LLC | 1 | $26 |
| Stryker | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,094
- WaveWriter Alpha Prime 16$608
- SPRINT PNS System$308
- GENERATOR$270
- PROCLAIM$174
- GENERAL PAIN MANAGEMENT$155
- Nalu Neurostimulation System$150
- XEOMIN$121
- Intracept$120
- BOTOX$107
- Qutenza$103
How this compares
$5,501 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 111 | $1,590 |
| Cyclobenzaprine Hcl | 29 | $1,146 |
| Duloxetine Hcl | 28 | $283 |
| Pregabalin | 14 | $237 |
| Methylprednisolone | 25 | $234 |
| Diclofenac Sodium | 20 | $145 |
| Tizanidine Hcl | 17 | $111 |
| Meloxicam | 36 | $85 |
| Methocarbamol | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Gulf Breeze
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.